All Stocks/Healthcare/BIO

BIO-RAD LABORATORIES, INC.

BIO
HealthcareMedical Devices Website
Price ChartPowered by TradingView
Ask about BIOAI research agent
Top Institutional HoldersFrom 13F filings
FundShares HeldPosition ValueAction (latest Q)
Citadel
Ken Griffin
12K$3.51MNEW
Marshall Wace12K$3.50MNEW
D.E. Shaw
David Shaw
5K$1.46MNEW
Politicians who traded BIOFrom Senate & House PTRs
PoliticianDateTypeAmount
Lois Frankel
D-FL
2023-09-08sale$1k – $15k
Lois Frankel
D-FL
2023-06-28purchase$1k – $15k
Thomas MacArthur
NJ
2015-05-27sale$1k – $15k
Thomas R Tillis2015-02-13sale$1k – $15k
About BIO-RAD LABORATORIES, INC.

Bio-Rad Laboratories Inc. operates as a leading manufacturer and distributor of life science research products and clinical diagnostics systems. Established in 1952 and headquartered in Hercules, California, the company plays a pivotal role in the healthcare and medical research sectors. Bio-Rad provides a broad range of products for life science research, including reagents, instruments, and software used for techniques such as gel electrophoresis, chromatography, and polymerase chain reaction (PCR). These tools facilitate advancements in biology and medical research, aiding in the discovery of genetic information and the analysis of cell functions. In the clinical diagnostics realm, Bio-Rad offers solutions used to identify, track, and diagnose diseases through blood and tissue analysis, impacting critical areas like diabetes testing, blood typing, and autoimmune disease testing. With a comprehensive portfolio that supports innovation and efficiency in research laboratories and hospitals, Bio-Rad Laboratories Inc. significantly contributes to the improvement of diagnostic procedures and research methodologies, cementing its role as a key player in the enhancement of global health and medical science.

CEO
Mr. Norman D. Schwartz
Employees
7,450
Quick Facts
Exchange–
SectorHealthcare
IndustryMedical Devices
Market Cap–
Key Dates

Earnings calendar coming soon. Subscribe to get notified when BIO reports next.

Get earnings alerts →